Status: Recruiting
Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients
The MODIFY CSX study is a prospective, randomized, placebo-controlled trial conducted in heart centers in Germany and Italy. A total of 550 high-risk cardiac surgery patients will receive either 0.20 g fish oil/kg body weight (BW) + standard of care versus same volume of placebo (NaCl) + standard of care.
Participants needed: 550
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: GCP-Service International West GmbHUpdated: Feb 23, 2026Locations: 10
Eligibility criteria
Written informed consent prior to study participation [+2]
Known hypersensitivity to fish oil/fish products or egg protein [+13]